Cargando…

Thalidomide and neurotrophism

BACKGROUND: Following the thalidomide disaster (1958–62), Henkel and Willert analysed the pattern of dysmelia in the long bones (J Bone Joint Surg Br. 51:399–414, 1969) and the extremities, Willert and Henkel (Z Orthop Ihre Grenzgeb. 107:663–75, 1970). Willert’s material from deformed extremities is...

Descripción completa

Detalles Bibliográficos
Autores principales: Soper, Judith R., Bonar, S. Fiona, O’Sullivan, Dudley J., McCredie, Janet, Willert, Hans-Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394469/
https://www.ncbi.nlm.nih.gov/pubmed/30341712
http://dx.doi.org/10.1007/s00256-018-3086-2
_version_ 1783398901494054912
author Soper, Judith R.
Bonar, S. Fiona
O’Sullivan, Dudley J.
McCredie, Janet
Willert, Hans-Georg
author_facet Soper, Judith R.
Bonar, S. Fiona
O’Sullivan, Dudley J.
McCredie, Janet
Willert, Hans-Georg
author_sort Soper, Judith R.
collection PubMed
description BACKGROUND: Following the thalidomide disaster (1958–62), Henkel and Willert analysed the pattern of dysmelia in the long bones (J Bone Joint Surg Br. 51:399–414, 1969) and the extremities, Willert and Henkel (Z Orthop Ihre Grenzgeb. 107:663–75, 1970). Willert’s material from deformed extremities is re-examined here asking “How does thalidomide reduce the skeleton?” MATERIALS AND METHODS: We reviewed the original data collection of Willert and Henkel (Z Orthop Ihre Grenzgeb. 107:663–75, 1970), comprising musculoskeletal histology slides from 30 children affected by thalidomide with radiographs of hands (19 cases) and feet (4 cases). RESULTS: All original observations by Willert and Henkel (Z Orthop Ihre Grenzgeb. 107:663–75, 1970), were verified. Radial rays of the hand disappeared early, but the foot was spared until late. Radiology confirms that bone reduction in the hand (aplasia or hypoplasia in the thumb and index finger) coincides with sensory segmental nerve C6. In the foot, reduction of the toes is rare, but mesenchymal excess (polydactyly) occurs in the hallux (L5 sclerotome), usually associated with absent tibia (L4 sclerotome). Histology confirms skeletal mesenchymal components to be unremarkable, contrasting with grossly abnormal bony architecture, a striking discordance between microscopic and macroscopic findings. No necrosis or vascular pathology was seen. CONCLUSION: The basic lesion was an abnormal quantity rather than quality of mesenchyme. Cell populations result from cellular proliferation, controlled in early limb bud formation by neurotrophism. Thalidomide is a known sensory neurotoxin in adults. In the embryo, sensorineural injury alters neurotrophism, causing increased or diminished cell proliferation in undifferentiated mesenchyme. Differentiation into normal cartilage occurs later, but within an altered mesenchymal mass. Reduction or excess deformity results, with normal histology, a significant finding. The primary pathological condition is not in the skeleton, but in the nerves.
format Online
Article
Text
id pubmed-6394469
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-63944692019-03-15 Thalidomide and neurotrophism Soper, Judith R. Bonar, S. Fiona O’Sullivan, Dudley J. McCredie, Janet Willert, Hans-Georg Skeletal Radiol Review Article BACKGROUND: Following the thalidomide disaster (1958–62), Henkel and Willert analysed the pattern of dysmelia in the long bones (J Bone Joint Surg Br. 51:399–414, 1969) and the extremities, Willert and Henkel (Z Orthop Ihre Grenzgeb. 107:663–75, 1970). Willert’s material from deformed extremities is re-examined here asking “How does thalidomide reduce the skeleton?” MATERIALS AND METHODS: We reviewed the original data collection of Willert and Henkel (Z Orthop Ihre Grenzgeb. 107:663–75, 1970), comprising musculoskeletal histology slides from 30 children affected by thalidomide with radiographs of hands (19 cases) and feet (4 cases). RESULTS: All original observations by Willert and Henkel (Z Orthop Ihre Grenzgeb. 107:663–75, 1970), were verified. Radial rays of the hand disappeared early, but the foot was spared until late. Radiology confirms that bone reduction in the hand (aplasia or hypoplasia in the thumb and index finger) coincides with sensory segmental nerve C6. In the foot, reduction of the toes is rare, but mesenchymal excess (polydactyly) occurs in the hallux (L5 sclerotome), usually associated with absent tibia (L4 sclerotome). Histology confirms skeletal mesenchymal components to be unremarkable, contrasting with grossly abnormal bony architecture, a striking discordance between microscopic and macroscopic findings. No necrosis or vascular pathology was seen. CONCLUSION: The basic lesion was an abnormal quantity rather than quality of mesenchyme. Cell populations result from cellular proliferation, controlled in early limb bud formation by neurotrophism. Thalidomide is a known sensory neurotoxin in adults. In the embryo, sensorineural injury alters neurotrophism, causing increased or diminished cell proliferation in undifferentiated mesenchyme. Differentiation into normal cartilage occurs later, but within an altered mesenchymal mass. Reduction or excess deformity results, with normal histology, a significant finding. The primary pathological condition is not in the skeleton, but in the nerves. Springer Berlin Heidelberg 2018-10-19 2019 /pmc/articles/PMC6394469/ /pubmed/30341712 http://dx.doi.org/10.1007/s00256-018-3086-2 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review Article
Soper, Judith R.
Bonar, S. Fiona
O’Sullivan, Dudley J.
McCredie, Janet
Willert, Hans-Georg
Thalidomide and neurotrophism
title Thalidomide and neurotrophism
title_full Thalidomide and neurotrophism
title_fullStr Thalidomide and neurotrophism
title_full_unstemmed Thalidomide and neurotrophism
title_short Thalidomide and neurotrophism
title_sort thalidomide and neurotrophism
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394469/
https://www.ncbi.nlm.nih.gov/pubmed/30341712
http://dx.doi.org/10.1007/s00256-018-3086-2
work_keys_str_mv AT soperjudithr thalidomideandneurotrophism
AT bonarsfiona thalidomideandneurotrophism
AT osullivandudleyj thalidomideandneurotrophism
AT mccrediejanet thalidomideandneurotrophism
AT willerthansgeorg thalidomideandneurotrophism